Bausch Health Companies Inc.

NYSE:BHC

5.76 (USD) • At close August 7, 2025
Bedrijfsnaam Bausch Health Companies Inc.
Symbool BHC
Munteenheid USD
Prijs 5.76
Beurswaarde 2,129,992,128
Dividendpercentage 0%
52-weken bereik 4.25 - 9.85
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Thomas J. Appio
Website https://www.bauschhealth.com

An error occurred while fetching data.

Over Bausch Health Companies Inc.

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.

Vergelijkbare Aandelen

CONMED Corporation logo

CONMED Corporation

CNMD

53.38 USD

MultiPlan Corporation logo

MultiPlan Corporation

MPLN

23.15 USD

Haemonetics Corporation logo

Haemonetics Corporation

HAE

55.63 USD

Select Medical Holdings Corporation logo

Select Medical Holdings Corporation

SEM

11.9 USD

Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc.

PBH

67.61 USD

Stevanato Group S.p.A. logo

Stevanato Group S.p.A.

STVN

24.2 USD

Evolent Health, Inc. logo

Evolent Health, Inc.

EVH

9.69 USD

Integer Holdings Corporation logo

Integer Holdings Corporation

ITGR

105.72 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)